Loading…

Engineering microbial consortia of Elizabethkingia meningoseptica and Escherichia coli strains for the biosynthesis of vitamin K2

The study and application of microbial consortia are topics of interest in the fields of metabolic engineering and synthetic biology. In this study, we report the design and optimisation of Elizabethkingia meningoseptica and Escherichia coli co-culture, which bypass certain limitations found during...

Full description

Saved in:
Bibliographic Details
Published in:Microbial cell factories 2022-03, Vol.21 (1), p.37-16, Article 37
Main Authors: Yang, Qiang, Zheng, Zhiming, Zhao, Genhai, Wang, Li, Wang, Han, Ding, XiuMin, Jiang, Chunxu, Li, Chu, Ma, Guoliang, Wang, Peng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c569t-230cb6e47fa801a0bf8e37e45f44c8f96b0bf410dab9b29399bf8484ca727a7d3
cites cdi_FETCH-LOGICAL-c569t-230cb6e47fa801a0bf8e37e45f44c8f96b0bf410dab9b29399bf8484ca727a7d3
container_end_page 16
container_issue 1
container_start_page 37
container_title Microbial cell factories
container_volume 21
creator Yang, Qiang
Zheng, Zhiming
Zhao, Genhai
Wang, Li
Wang, Han
Ding, XiuMin
Jiang, Chunxu
Li, Chu
Ma, Guoliang
Wang, Peng
description The study and application of microbial consortia are topics of interest in the fields of metabolic engineering and synthetic biology. In this study, we report the design and optimisation of Elizabethkingia meningoseptica and Escherichia coli co-culture, which bypass certain limitations found during the molecular modification of E. meningoseptica, such as resistance to many antibiotics and fewer available molecular tools. The octaprenyl pyrophosphate synthase from E. meningoseptica sp. F2 (EmOPPS) was expressed, purified, and identified in the present study. Then, owing to the low vitamin K2 production by E. coli or E. meningoseptica sp. F2 monoculture, we introduced the E. meningoseptica and E. coli co-culture strategy to improve vitamin K2 biosynthesis. We achieved production titres of 32 mg/L by introducing vitamin K2 synthesis-related genes from E. meningoseptica sp. F2 into E. coli, which were approximately three-fold more than the titre achieved with E. meningoseptica sp. F2 monoculture. This study establishes a foundation for further engineering of MK-n (n = 4, 5, 6, 7, 8) in a co-cultivation system of E. meningoseptica and E. coli. Finally, we analysed the surface morphology, esterase activity, and membrane permeability of these microbial consortia using scanning electron microscopy, confocal laser scanning microscopy, and flow cytometry, respectively. The results showed that the co-cultured bacteria were closely linked and that lipase activity and membrane permeability improved, which may be conducive to the exchange of substances between bacteria. Our results demonstrated that co-culture engineering can be a useful method in the broad field of metabolic engineering of strains with restricted molecular modifications.
doi_str_mv 10.1186/s12934-022-01768-7
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b4ca9dca56a2429bb67057cbd7758901</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A699525629</galeid><doaj_id>oai_doaj_org_article_b4ca9dca56a2429bb67057cbd7758901</doaj_id><sourcerecordid>A699525629</sourcerecordid><originalsourceid>FETCH-LOGICAL-c569t-230cb6e47fa801a0bf8e37e45f44c8f96b0bf410dab9b29399bf8484ca727a7d3</originalsourceid><addsrcrecordid>eNptkk1v1DAQhiMEomXhD3BAlriUQ4rjJP64IFXVUlZUQuLjbI0dJ3FJ7CXOVpQb_7yzTam6Esoho5n3fZKx3yx7XdDTopD8fSqYKqucMpbTQnCZiyfZcVGJOmeyVk8f1UfZi5SuKKqkKJ9nR2XNhMLpcfZ3HTofnJt86Mjo7RSNh4HYGFKcZg8ktmQ9-D9g3Nz_RBG2RhewiMltZ2-BQGjIOtkeGbbHsY2DJ2mewIdE2jiRuXfE-JhuAlbJpz3z2s8w-kA-s5fZsxaG5F7dv1fZj4_r7-ef8ssvF5vzs8vc1lzNOSupNdxVogVJC6Cmla4UrqrbqrKyVdxgqypoA0YZPBelUFHJyoJgAkRTrrLNwm0iXOnt5EeYbnQEr-8aceo04MZ2cNqgSzUWag6sYsoYLmgtrGmEqKWiBbI-LKztzoyusS7gusMB9HASfK-7eK2lwosSEgEn94Ap_tq5NOvRJ-uGAYKLu6QZL6XiVIj9t94u0g7w13xoIxLtXq7PuFI1qzmuu8pO_6PCp3F4qzG41mP_wPDuwICa2f2eO9ilpDffvh5q2aLFeKQ0ufZh04LqfRT1EkWNUdR3UdQCTW8en9GD5V_2yluGMdtx</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638960771</pqid></control><display><type>article</type><title>Engineering microbial consortia of Elizabethkingia meningoseptica and Escherichia coli strains for the biosynthesis of vitamin K2</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Yang, Qiang ; Zheng, Zhiming ; Zhao, Genhai ; Wang, Li ; Wang, Han ; Ding, XiuMin ; Jiang, Chunxu ; Li, Chu ; Ma, Guoliang ; Wang, Peng</creator><creatorcontrib>Yang, Qiang ; Zheng, Zhiming ; Zhao, Genhai ; Wang, Li ; Wang, Han ; Ding, XiuMin ; Jiang, Chunxu ; Li, Chu ; Ma, Guoliang ; Wang, Peng</creatorcontrib><description>The study and application of microbial consortia are topics of interest in the fields of metabolic engineering and synthetic biology. In this study, we report the design and optimisation of Elizabethkingia meningoseptica and Escherichia coli co-culture, which bypass certain limitations found during the molecular modification of E. meningoseptica, such as resistance to many antibiotics and fewer available molecular tools. The octaprenyl pyrophosphate synthase from E. meningoseptica sp. F2 (EmOPPS) was expressed, purified, and identified in the present study. Then, owing to the low vitamin K2 production by E. coli or E. meningoseptica sp. F2 monoculture, we introduced the E. meningoseptica and E. coli co-culture strategy to improve vitamin K2 biosynthesis. We achieved production titres of 32 mg/L by introducing vitamin K2 synthesis-related genes from E. meningoseptica sp. F2 into E. coli, which were approximately three-fold more than the titre achieved with E. meningoseptica sp. F2 monoculture. This study establishes a foundation for further engineering of MK-n (n = 4, 5, 6, 7, 8) in a co-cultivation system of E. meningoseptica and E. coli. Finally, we analysed the surface morphology, esterase activity, and membrane permeability of these microbial consortia using scanning electron microscopy, confocal laser scanning microscopy, and flow cytometry, respectively. The results showed that the co-cultured bacteria were closely linked and that lipase activity and membrane permeability improved, which may be conducive to the exchange of substances between bacteria. Our results demonstrated that co-culture engineering can be a useful method in the broad field of metabolic engineering of strains with restricted molecular modifications.</description><identifier>ISSN: 1475-2859</identifier><identifier>EISSN: 1475-2859</identifier><identifier>DOI: 10.1186/s12934-022-01768-7</identifier><identifier>PMID: 35279147</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Chryseobacterium ; Consortia ; Elizabethkingia meningoseptica ; Escherichia coli ; Escherichia coli - genetics ; Escherichia coli - metabolism ; Evaluation ; Flavobacteriaceae Infections ; Genetic aspects ; Gram-negative bacteria ; Humans ; Metabolic engineering ; Microbial consortia ; Microbial Consortia - genetics ; Properties ; Quinone ; Vitamin K ; Vitamin K 2 - metabolism ; Vitamin K2</subject><ispartof>Microbial cell factories, 2022-03, Vol.21 (1), p.37-16, Article 37</ispartof><rights>2022. The Author(s).</rights><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c569t-230cb6e47fa801a0bf8e37e45f44c8f96b0bf410dab9b29399bf8484ca727a7d3</citedby><cites>FETCH-LOGICAL-c569t-230cb6e47fa801a0bf8e37e45f44c8f96b0bf410dab9b29399bf8484ca727a7d3</cites><orcidid>0000-0002-0550-8087</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917678/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917678/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35279147$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Qiang</creatorcontrib><creatorcontrib>Zheng, Zhiming</creatorcontrib><creatorcontrib>Zhao, Genhai</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Wang, Han</creatorcontrib><creatorcontrib>Ding, XiuMin</creatorcontrib><creatorcontrib>Jiang, Chunxu</creatorcontrib><creatorcontrib>Li, Chu</creatorcontrib><creatorcontrib>Ma, Guoliang</creatorcontrib><creatorcontrib>Wang, Peng</creatorcontrib><title>Engineering microbial consortia of Elizabethkingia meningoseptica and Escherichia coli strains for the biosynthesis of vitamin K2</title><title>Microbial cell factories</title><addtitle>Microb Cell Fact</addtitle><description>The study and application of microbial consortia are topics of interest in the fields of metabolic engineering and synthetic biology. In this study, we report the design and optimisation of Elizabethkingia meningoseptica and Escherichia coli co-culture, which bypass certain limitations found during the molecular modification of E. meningoseptica, such as resistance to many antibiotics and fewer available molecular tools. The octaprenyl pyrophosphate synthase from E. meningoseptica sp. F2 (EmOPPS) was expressed, purified, and identified in the present study. Then, owing to the low vitamin K2 production by E. coli or E. meningoseptica sp. F2 monoculture, we introduced the E. meningoseptica and E. coli co-culture strategy to improve vitamin K2 biosynthesis. We achieved production titres of 32 mg/L by introducing vitamin K2 synthesis-related genes from E. meningoseptica sp. F2 into E. coli, which were approximately three-fold more than the titre achieved with E. meningoseptica sp. F2 monoculture. This study establishes a foundation for further engineering of MK-n (n = 4, 5, 6, 7, 8) in a co-cultivation system of E. meningoseptica and E. coli. Finally, we analysed the surface morphology, esterase activity, and membrane permeability of these microbial consortia using scanning electron microscopy, confocal laser scanning microscopy, and flow cytometry, respectively. The results showed that the co-cultured bacteria were closely linked and that lipase activity and membrane permeability improved, which may be conducive to the exchange of substances between bacteria. Our results demonstrated that co-culture engineering can be a useful method in the broad field of metabolic engineering of strains with restricted molecular modifications.</description><subject>Chryseobacterium</subject><subject>Consortia</subject><subject>Elizabethkingia meningoseptica</subject><subject>Escherichia coli</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - metabolism</subject><subject>Evaluation</subject><subject>Flavobacteriaceae Infections</subject><subject>Genetic aspects</subject><subject>Gram-negative bacteria</subject><subject>Humans</subject><subject>Metabolic engineering</subject><subject>Microbial consortia</subject><subject>Microbial Consortia - genetics</subject><subject>Properties</subject><subject>Quinone</subject><subject>Vitamin K</subject><subject>Vitamin K 2 - metabolism</subject><subject>Vitamin K2</subject><issn>1475-2859</issn><issn>1475-2859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkk1v1DAQhiMEomXhD3BAlriUQ4rjJP64IFXVUlZUQuLjbI0dJ3FJ7CXOVpQb_7yzTam6Esoho5n3fZKx3yx7XdDTopD8fSqYKqucMpbTQnCZiyfZcVGJOmeyVk8f1UfZi5SuKKqkKJ9nR2XNhMLpcfZ3HTofnJt86Mjo7RSNh4HYGFKcZg8ktmQ9-D9g3Nz_RBG2RhewiMltZ2-BQGjIOtkeGbbHsY2DJ2mewIdE2jiRuXfE-JhuAlbJpz3z2s8w-kA-s5fZsxaG5F7dv1fZj4_r7-ef8ssvF5vzs8vc1lzNOSupNdxVogVJC6Cmla4UrqrbqrKyVdxgqypoA0YZPBelUFHJyoJgAkRTrrLNwm0iXOnt5EeYbnQEr-8aceo04MZ2cNqgSzUWag6sYsoYLmgtrGmEqKWiBbI-LKztzoyusS7gusMB9HASfK-7eK2lwosSEgEn94Ap_tq5NOvRJ-uGAYKLu6QZL6XiVIj9t94u0g7w13xoIxLtXq7PuFI1qzmuu8pO_6PCp3F4qzG41mP_wPDuwICa2f2eO9ilpDffvh5q2aLFeKQ0ufZh04LqfRT1EkWNUdR3UdQCTW8en9GD5V_2yluGMdtx</recordid><startdate>20220312</startdate><enddate>20220312</enddate><creator>Yang, Qiang</creator><creator>Zheng, Zhiming</creator><creator>Zhao, Genhai</creator><creator>Wang, Li</creator><creator>Wang, Han</creator><creator>Ding, XiuMin</creator><creator>Jiang, Chunxu</creator><creator>Li, Chu</creator><creator>Ma, Guoliang</creator><creator>Wang, Peng</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0550-8087</orcidid></search><sort><creationdate>20220312</creationdate><title>Engineering microbial consortia of Elizabethkingia meningoseptica and Escherichia coli strains for the biosynthesis of vitamin K2</title><author>Yang, Qiang ; Zheng, Zhiming ; Zhao, Genhai ; Wang, Li ; Wang, Han ; Ding, XiuMin ; Jiang, Chunxu ; Li, Chu ; Ma, Guoliang ; Wang, Peng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c569t-230cb6e47fa801a0bf8e37e45f44c8f96b0bf410dab9b29399bf8484ca727a7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Chryseobacterium</topic><topic>Consortia</topic><topic>Elizabethkingia meningoseptica</topic><topic>Escherichia coli</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - metabolism</topic><topic>Evaluation</topic><topic>Flavobacteriaceae Infections</topic><topic>Genetic aspects</topic><topic>Gram-negative bacteria</topic><topic>Humans</topic><topic>Metabolic engineering</topic><topic>Microbial consortia</topic><topic>Microbial Consortia - genetics</topic><topic>Properties</topic><topic>Quinone</topic><topic>Vitamin K</topic><topic>Vitamin K 2 - metabolism</topic><topic>Vitamin K2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Qiang</creatorcontrib><creatorcontrib>Zheng, Zhiming</creatorcontrib><creatorcontrib>Zhao, Genhai</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Wang, Han</creatorcontrib><creatorcontrib>Ding, XiuMin</creatorcontrib><creatorcontrib>Jiang, Chunxu</creatorcontrib><creatorcontrib>Li, Chu</creatorcontrib><creatorcontrib>Ma, Guoliang</creatorcontrib><creatorcontrib>Wang, Peng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Microbial cell factories</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Qiang</au><au>Zheng, Zhiming</au><au>Zhao, Genhai</au><au>Wang, Li</au><au>Wang, Han</au><au>Ding, XiuMin</au><au>Jiang, Chunxu</au><au>Li, Chu</au><au>Ma, Guoliang</au><au>Wang, Peng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engineering microbial consortia of Elizabethkingia meningoseptica and Escherichia coli strains for the biosynthesis of vitamin K2</atitle><jtitle>Microbial cell factories</jtitle><addtitle>Microb Cell Fact</addtitle><date>2022-03-12</date><risdate>2022</risdate><volume>21</volume><issue>1</issue><spage>37</spage><epage>16</epage><pages>37-16</pages><artnum>37</artnum><issn>1475-2859</issn><eissn>1475-2859</eissn><abstract>The study and application of microbial consortia are topics of interest in the fields of metabolic engineering and synthetic biology. In this study, we report the design and optimisation of Elizabethkingia meningoseptica and Escherichia coli co-culture, which bypass certain limitations found during the molecular modification of E. meningoseptica, such as resistance to many antibiotics and fewer available molecular tools. The octaprenyl pyrophosphate synthase from E. meningoseptica sp. F2 (EmOPPS) was expressed, purified, and identified in the present study. Then, owing to the low vitamin K2 production by E. coli or E. meningoseptica sp. F2 monoculture, we introduced the E. meningoseptica and E. coli co-culture strategy to improve vitamin K2 biosynthesis. We achieved production titres of 32 mg/L by introducing vitamin K2 synthesis-related genes from E. meningoseptica sp. F2 into E. coli, which were approximately three-fold more than the titre achieved with E. meningoseptica sp. F2 monoculture. This study establishes a foundation for further engineering of MK-n (n = 4, 5, 6, 7, 8) in a co-cultivation system of E. meningoseptica and E. coli. Finally, we analysed the surface morphology, esterase activity, and membrane permeability of these microbial consortia using scanning electron microscopy, confocal laser scanning microscopy, and flow cytometry, respectively. The results showed that the co-cultured bacteria were closely linked and that lipase activity and membrane permeability improved, which may be conducive to the exchange of substances between bacteria. Our results demonstrated that co-culture engineering can be a useful method in the broad field of metabolic engineering of strains with restricted molecular modifications.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>35279147</pmid><doi>10.1186/s12934-022-01768-7</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-0550-8087</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1475-2859
ispartof Microbial cell factories, 2022-03, Vol.21 (1), p.37-16, Article 37
issn 1475-2859
1475-2859
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_b4ca9dca56a2429bb67057cbd7758901
source Publicly Available Content Database; PubMed Central
subjects Chryseobacterium
Consortia
Elizabethkingia meningoseptica
Escherichia coli
Escherichia coli - genetics
Escherichia coli - metabolism
Evaluation
Flavobacteriaceae Infections
Genetic aspects
Gram-negative bacteria
Humans
Metabolic engineering
Microbial consortia
Microbial Consortia - genetics
Properties
Quinone
Vitamin K
Vitamin K 2 - metabolism
Vitamin K2
title Engineering microbial consortia of Elizabethkingia meningoseptica and Escherichia coli strains for the biosynthesis of vitamin K2
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A40%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engineering%20microbial%20consortia%20of%20Elizabethkingia%20meningoseptica%20and%20Escherichia%20coli%20strains%20for%20the%20biosynthesis%20of%20vitamin%20K2&rft.jtitle=Microbial%20cell%20factories&rft.au=Yang,%20Qiang&rft.date=2022-03-12&rft.volume=21&rft.issue=1&rft.spage=37&rft.epage=16&rft.pages=37-16&rft.artnum=37&rft.issn=1475-2859&rft.eissn=1475-2859&rft_id=info:doi/10.1186/s12934-022-01768-7&rft_dat=%3Cgale_doaj_%3EA699525629%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c569t-230cb6e47fa801a0bf8e37e45f44c8f96b0bf410dab9b29399bf8484ca727a7d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2638960771&rft_id=info:pmid/35279147&rft_galeid=A699525629&rfr_iscdi=true